| 9401 |
TBS Holdings, Inc.
|
Earnings |
|
Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 4554 |
Fuji Pharmaceutical Industries Co., Ltd.
|
Earnings |
|
Notice Regarding Revision of Earnings Guidance
|
Feb 5, 2026
|
| 4554 |
Fuji Pharmaceutical Co., Ltd.
|
Earnings |
|
Notice Regarding Securities Valuation Loss for the First Quarter of the Fiscal Year Ending September 2026
|
Feb 5, 2026
|
| 4554 |
Fuji Pharmaceutical Industrial Co., Ltd.
|
Earnings |
|
Financial Summary for Q1 FY2026 Ending September (Japan GAAP) (Consolidated)
|
Feb 5, 2026
|
| 4107 |
Ise Chemical Industry Co., Ltd.
|
M&A |
|
Notice Regarding Organizational Restructuring
|
Feb 5, 2026
|
| 4107 |
Ise Chemical Industry Co., Ltd.
|
Personnel |
|
Notice of Changes in Directors and Executive Officers and Other Personnel Changes
|
Feb 5, 2026
|
| 4107 |
Ise Chemical Industry Co., Ltd.
|
Personnel |
|
Notice Regarding Change of Representative Director (Additional Appointment)
|
Feb 5, 2026
|
| 4107 |
Ise Chemicals Corporation
|
Earnings |
|
Supplementary Explanation Material for the Fiscal Year Ending December 2025 Financial Results
|
Feb 5, 2026
|
| 4107 |
Ise Chemical Industry Co., Ltd.
|
Earnings |
|
Financial Summary for the Fiscal Year Ending December 2025 [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 2108 |
Japan Sugar Manufacturing Co., Ltd.
|
Other |
|
Notice Regarding Changes in Major Shareholders and the Largest Major Shareholder
|
Feb 5, 2026
|
| 7211 |
Mitsubishi Motors Corporation
|
Earnings |
|
Fiscal Year March 2026 Q3 Financial Summary〔Japanese GAAP〕(Consolidated)
|
Feb 5, 2026
|
| 8584 |
JACCS Co., Ltd.
|
M&A |
|
Notice Regarding Entry into the Financial Business in Singapore
|
Feb 5, 2026
|
| 8584 |
JACCS Co., Ltd.
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 3593 |
Hogi Medical Co., Ltd.
|
M&A |
|
(Amendment) Notice Regarding Changes to the Expression of Opinion in Support and Recommendation to Apply for the Tender Offer by TCG2509 Co., Ltd. for Shares of the Company
|
Feb 5, 2026
|
| 3593 |
Hogi Medical Co., Ltd.
|
M&A |
|
(Correction) Notice Regarding Correction of “Announcement of Commencement of Tender Offer for Common Shares of Hogi Medical Co., Ltd. (Securities Code: 3593) by TCG2509 Co., Ltd.”
|
Feb 5, 2026
|
| 9715 |
Transcosmos Inc.
|
Earnings |
|
Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 9684 |
Square Enix Holdings Co., Ltd.
|
Other |
|
Notice Regarding Introduction of Shareholder Benefits Program
|
Feb 5, 2026
|
| 9684 |
Square Enix Holdings Co., Ltd.
|
Earnings |
|
Notice Regarding Revision of Full-Year Consolidated Earnings Guidance
|
Feb 5, 2026
|
| 9684 |
SQUARE ENIX HOLDINGS CO., LTD.
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Results Briefing
|
Feb 5, 2026
|
| 9684 |
Square Enix Holdings Co., Ltd.
|
Earnings |
|
Financial Summary for the Third Quarter of Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
